Cargando…
The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population
PURPOSE: Emerging evidence suggested that metabolic dysfunction-associated fatty liver disease (MAFLD) was significantly associated with atherosclerotic diseases. Atherosclerosis in the peripheral arteries is the most common cause of peripheral arterial disease (PAD), which has not been substantiall...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926992/ https://www.ncbi.nlm.nih.gov/pubmed/36798909 http://dx.doi.org/10.2147/DMSO.S394414 |
_version_ | 1784888389434081280 |
---|---|
author | Song, Xiao-Hui Liu, Bo Lei, Fang Liu, Ye-Mao Zhang, Xingyuan Chen, Ze Zhang, Peng Zhang, Xiao-Jing She, Zhi-Gang Cai, Jingjing Wang, Jin-Hua Li, Hongliang |
author_facet | Song, Xiao-Hui Liu, Bo Lei, Fang Liu, Ye-Mao Zhang, Xingyuan Chen, Ze Zhang, Peng Zhang, Xiao-Jing She, Zhi-Gang Cai, Jingjing Wang, Jin-Hua Li, Hongliang |
author_sort | Song, Xiao-Hui |
collection | PubMed |
description | PURPOSE: Emerging evidence suggested that metabolic dysfunction-associated fatty liver disease (MAFLD) was significantly associated with atherosclerotic diseases. Atherosclerosis in the peripheral arteries is the most common cause of peripheral arterial disease (PAD), which has not been substantially controlled in the past. We aimed to investigate the association between MAFLD and PAD in the Chinese population. PATIENTS AND METHODS: This observational study covered 102,115 participants who underwent health checkups with detailed examinations for PAD and MAFLD. PAD was measured by ankle-brachial index, and MAFLD was diagnosed by abdominal ultrasound. The generalized linear mixed models and random-effects Cox proportional hazards models were used to analyze the relationship between MAFLD and PAD. RESULTS: The baseline characteristics showed that patients with MAFLD had higher prevalence of PAD compared with those without MAFLD (2.7% vs 2.2%). Compared to non-MAFLD, the individuals with MAFLD were associated with a higher risk of the presence of PAD (adjusted odds ratio: 1.30, 95% confidence interval (CI): 1.19–1.42, P < 0.001). In the prospective cohort study, 6833 participants underwent a follow-up of 2.76 (standard deviation: 1.36) years, and MAFLD at baseline was a higher risk of associated with incident PAD (adjusted hazards ratio: 1.67, 95% CI: 1.17–2.38, P = 0.005). Moreover, with the accumulation of metabolic abnormalities, the risk of the PAD was increased in the individuals with MAFLD. Furthermore, MAFLD attributed risk of PAD was more evident in participants without metabolic comorbidities. CONCLUSION: MAFLD was associated with a significantly higher risk for the prevalence and incidence of PAD in the Chinese population. The finding suggested that individuals with MAFLD are not only have a higher risk of coronary heart diseases but also have an increased risk of atherosclerosis in peripheral arteries. |
format | Online Article Text |
id | pubmed-9926992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-99269922023-02-15 The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population Song, Xiao-Hui Liu, Bo Lei, Fang Liu, Ye-Mao Zhang, Xingyuan Chen, Ze Zhang, Peng Zhang, Xiao-Jing She, Zhi-Gang Cai, Jingjing Wang, Jin-Hua Li, Hongliang Diabetes Metab Syndr Obes Original Research PURPOSE: Emerging evidence suggested that metabolic dysfunction-associated fatty liver disease (MAFLD) was significantly associated with atherosclerotic diseases. Atherosclerosis in the peripheral arteries is the most common cause of peripheral arterial disease (PAD), which has not been substantially controlled in the past. We aimed to investigate the association between MAFLD and PAD in the Chinese population. PATIENTS AND METHODS: This observational study covered 102,115 participants who underwent health checkups with detailed examinations for PAD and MAFLD. PAD was measured by ankle-brachial index, and MAFLD was diagnosed by abdominal ultrasound. The generalized linear mixed models and random-effects Cox proportional hazards models were used to analyze the relationship between MAFLD and PAD. RESULTS: The baseline characteristics showed that patients with MAFLD had higher prevalence of PAD compared with those without MAFLD (2.7% vs 2.2%). Compared to non-MAFLD, the individuals with MAFLD were associated with a higher risk of the presence of PAD (adjusted odds ratio: 1.30, 95% confidence interval (CI): 1.19–1.42, P < 0.001). In the prospective cohort study, 6833 participants underwent a follow-up of 2.76 (standard deviation: 1.36) years, and MAFLD at baseline was a higher risk of associated with incident PAD (adjusted hazards ratio: 1.67, 95% CI: 1.17–2.38, P = 0.005). Moreover, with the accumulation of metabolic abnormalities, the risk of the PAD was increased in the individuals with MAFLD. Furthermore, MAFLD attributed risk of PAD was more evident in participants without metabolic comorbidities. CONCLUSION: MAFLD was associated with a significantly higher risk for the prevalence and incidence of PAD in the Chinese population. The finding suggested that individuals with MAFLD are not only have a higher risk of coronary heart diseases but also have an increased risk of atherosclerosis in peripheral arteries. Dove 2023-02-10 /pmc/articles/PMC9926992/ /pubmed/36798909 http://dx.doi.org/10.2147/DMSO.S394414 Text en © 2023 Song et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Song, Xiao-Hui Liu, Bo Lei, Fang Liu, Ye-Mao Zhang, Xingyuan Chen, Ze Zhang, Peng Zhang, Xiao-Jing She, Zhi-Gang Cai, Jingjing Wang, Jin-Hua Li, Hongliang The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population |
title | The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population |
title_full | The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population |
title_fullStr | The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population |
title_full_unstemmed | The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population |
title_short | The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population |
title_sort | association between metabolic dysfunction-associated fatty liver disease and peripheral arterial disease in the chinese population |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926992/ https://www.ncbi.nlm.nih.gov/pubmed/36798909 http://dx.doi.org/10.2147/DMSO.S394414 |
work_keys_str_mv | AT songxiaohui theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT liubo theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT leifang theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT liuyemao theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT zhangxingyuan theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT chenze theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT zhangpeng theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT zhangxiaojing theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT shezhigang theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT caijingjing theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT wangjinhua theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT lihongliang theassociationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT songxiaohui associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT liubo associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT leifang associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT liuyemao associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT zhangxingyuan associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT chenze associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT zhangpeng associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT zhangxiaojing associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT shezhigang associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT caijingjing associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT wangjinhua associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation AT lihongliang associationbetweenmetabolicdysfunctionassociatedfattyliverdiseaseandperipheralarterialdiseaseinthechinesepopulation |